Zobrazeno 1 - 10
of 354
pro vyhledávání: '"M Kozloff"'
Autor:
Yuki Matsushita, Mizuki Nagata, Kenneth M. Kozloff, Joshua D. Welch, Koji Mizuhashi, Nicha Tokavanich, Shawn A. Hallett, Daniel C. Link, Takashi Nagasawa, Wanida Ono, Noriaki Ono
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-17 (2020)
Bone marrow stromal cells (BMSCs) lining sinusoidal blood vessels are mesenchymal cells whose function is critical for the skeleton. Here the authors show that quiescent CXCL12-expressing BMSCs can convert into a skeletal stem cell-like state, and di
Externí odkaz:
https://doaj.org/article/ddf85b9902a447478bc6eb1f3abe22df
Publikováno v:
Photoacoustics, Vol 23, Iss , Pp 100273- (2021)
The photoacoustic (PA) technique is uniquely positioned for biomedical applications primarily due to its ability to visualize optical absorption contrast in deep tissue at ultrasound resolution. In this work, via both three-dimensional (3D) numerical
Externí odkaz:
https://doaj.org/article/4245b4af4bf3418ca732620c844ac69f
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-15 (2019)
Prior evidence suggested mesenchymal stromal cells (MSCs) required for skeletal formation, maintenance, and repair arise postnatally. Here, the authors show that Hoxa11 lineage-marked cells give rise to all skeletal lineages from embryogenesis throug
Externí odkaz:
https://doaj.org/article/f7ea0e26660043b5baab7d27f61badf5
Autor:
Isabel D. Colón-Bernal, Le T. Duong, Brenda Pennypacker, James Henderson, Kenneth M. Kozloff, Mark M. Banaszak Holl
Publikováno v:
Bone Reports, Vol 9, Iss , Pp 159-164 (2018)
Anti-resorptive drugs treat bone loss by blocking osteoclast activity through a variety of mechanisms of action. Once significant bone loss has occurred, the ability to restore biomechanical function may differ based on the drug chosen. To assess thi
Externí odkaz:
https://doaj.org/article/19b67fafdfc840fa834223fe7b3628d4
Autor:
Gali Guterman-Ram, Ghazal Hedjazi, Chris Stephan, Stéphane Blouin, Jochen Zwerina, Kenneth M. Kozloff, Nadja Fratzl-Zelman, Joan C. Marini
Publikováno v:
Bone Reports, Vol 14, Iss , Pp 100805- (2021)
Externí odkaz:
https://doaj.org/article/a45a9a8a355d4c069d4e835dad533cbf
Autor:
Gali Guterman-Ram, Ghazal Hedjazi, Chris Stephan, Stéphane Blouin, Paul Roschger, Klaus Klaushofer, Jochen Zwerina, Kenneth M. Kozloff, Nadja Fratzl-Zelman, Joan C. Marini
Publikováno v:
Bone Reports, Vol 13, Iss , Pp 100650- (2020)
Externí odkaz:
https://doaj.org/article/e86fe0bcedb1451fae44b9cee29bd749
Autor:
Rachel K Surowiec, Lauren F Battle, Stephen H Schlecht, Edward M Wojtys, Michelle S Caird, Kenneth M Kozloff
Publikováno v:
JBMR Plus, Vol 4, Iss 8, Pp n/a-n/a (2020)
ABSTRACT Sclerostin antibody (SclAb) therapy has been suggested as a novel therapeutic approach toward addressing the fragility phenotypic of osteogenesis imperfecta (OI). Observations of cellular and transcriptional responses to SclAb in OI have bee
Externí odkaz:
https://doaj.org/article/cbfd8e3851e5441bb244cc6d8d62d469
Publikováno v:
BME Frontiers, Vol 2020 (2020)
Objective and Impact Statement. To study the feasibility of combined functional photoacoustic (PA) and quantitative ultrasound (US) for diagnosis of osteoporosis in vivo based on the detection of chemical and microarchitecture (BMA) information in ca
Externí odkaz:
https://doaj.org/article/c664027978f3467a9cdbd4e4a5b15e4e
Autor:
Silvia Concetta Colucci, Cinzia Buccoliero, Lorenzo Sanesi, Mariella Errede, Graziana Colaianni, Tiziana Annese, Mohd Parvez Khan, Roberta Zerlotin, Manuela Dicarlo, Ernestina Schipani, Kenneth M. Kozloff, Maria Grano
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 19, p 10863 (2021)
To date, pharmacological strategies designed to accelerate bone fracture healing are lacking. We subjected 8-week-old C57BL/6 male mice to closed, transverse, mid-diaphyseal tibial fractures and treated them with intraperitoneal injection of a vehicl
Externí odkaz:
https://doaj.org/article/cafdcb5aa625482c9a8f93d4047d79b4
Autor:
Evan T. Keller, Frauke Schimmoller, Dana T. Aftab, Kenneth M. Kozloff, Jill M. Keller, Andreas Karatsinides, Honglai Zhang, Jinlu Dai
Purpose: Cabozantinib, an orally available multityrosine kinase inhibitor with activity against mesenchymal epithelial transition factor (MET) and VEGF receptor 2 (VEGFR2), induces resolution of bone scan lesions in men with castration-resistant pros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e90b4ae117a196de7881ec25596e13c
https://doi.org/10.1158/1078-0432.c.6521700
https://doi.org/10.1158/1078-0432.c.6521700